Table 2 Patient characteristics and treatment
Age (yrs) | Percent Patients (n = 100) |
|---|---|
 < 60 | 8 |
 60-69 | 45 |
 70-79 | 43 |
 ≥ 80 | 4 |
Race | Â |
 White | 56 |
 Black | 37 |
 Hispanic | 5 |
 Asian | 2 |
Pre-Tx PSA (ng/ml) | Â |
 ≤ 10 | 87 |
 > 10 and ≤ 20 | 12 |
 > 20 | 1 |
T Stage | Â |
 T1b | 1 |
 T1c | 75 |
 T2a | 12 |
 T2b | 8 |
 T2c | 4 |
Gleason Score | Â |
 2 + 3 = 5 | 2 |
 3 + 2 = 5 | 1 |
 3 + 3 = 6 | 42 |
 3 + 4 = 7 | 40 |
 4 + 3 = 7 | 10 |
 3 + 5 = 8 | 1 |
 4 + 4 = 8 | 4 |
Risk Groups | Â |
 Low Risk | 37 |
 Intermediate Risk | 55 |
 High Risk | 8 |
Hormone Treatment | Â |
 Yes | 11 |
 No | 89 |
Dose (Gy) | Â |
 35.00 | 15 |
 36.25 | 85 |